Literature DB >> 27383774

Risk of Lung Cancer Associated with COPD Phenotype Based on Quantitative Image Analysis.

Ann G Schwartz1, Christine M Lusk2, Angela S Wenzlaff2, Donovan Watza3, Stephanie Pandolfi3, Laura Mantha4, Michele L Cote2, Ayman O Soubani5, Garrett Walworth6, Antoinette Wozniak2, Christine Neslund-Dudas7, Amy A Ardisana7, Michael J Flynn8, Thomas Song8, David L Spizarny8, Paul A Kvale9, Robert A Chapman10, Shirish M Gadgeel2.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer. This study evaluates alternative measures of COPD based on spirometry and quantitative image analysis to better define a phenotype that predicts lung cancer risk.
METHODS: A total of 341 lung cancer cases and 752 volunteer controls, ages 21 to 89 years, participated in a structured interview, standardized CT scan, and spirometry. Logistic regression, adjusted for age, race, gender, pack-years, and inspiratory and expiratory total lung volume, was used to estimate the odds of lung cancer associated with FEV1/FVC, percent voxels less than -950 Hounsfield units on the inspiratory scan (HUI) and percent voxels less than -856 HU on expiratory scan (HUE).
RESULTS: The odds of lung cancer were increased 1.4- to 3.1-fold among those with COPD compared with those without, regardless of assessment method; however, in multivariable modeling, only percent voxels <-856 HUE as a continuous measure of air trapping [OR = 1.04; 95% confidence interval (CI), 1.03-1.06] and FEV1/FVC < 0.70 (OR = 1.71; 95% CI, 1.21-2.41) were independent predictors of lung cancer risk. Nearly 10% of lung cancer cases were negative on all objective measures of COPD.
CONCLUSION: Measures of air trapping using quantitative imaging, in addition to FEV1/FVC, can identify individuals at high risk of lung cancer and should be considered as supplementary measures at the time of screening for lung cancer. IMPACT: Quantitative measures of air trapping based on imaging provide additional information for the identification of high-risk groups who might benefit the most from lung cancer screening. Cancer Epidemiol Biomarkers Prev; 25(9); 1341-7. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27383774      PMCID: PMC5010488          DOI: 10.1158/1055-9965.EPI-16-0176

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

1.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee.

Authors:  Lorcan P McGarvey; Matthias John; Julie A Anderson; Michael Zvarich; Robert A Wise
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

2.  Family history of cancer and risk of lung cancer in lifetime non-smokers and long-term ex-smokers.

Authors:  R C Brownson; M C Alavanja; N Caporaso; E Berger; J C Chang
Journal:  Int J Epidemiol       Date:  1997-04       Impact factor: 7.196

3.  A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation.

Authors:  R Graham Barr; Eugene A Berkowitz; Francesca Bigazzi; Frederick Bode; Jessica Bon; Russell P Bowler; Caroline Chiles; James D Crapo; Gerard J Criner; Jeffrey L Curtis; Chandra Dass; Asger Dirksen; Mark T Dransfield; Goutham Edula; Leif Erikkson; Adam Friedlander; Maya Galperin-Aizenberg; Warren B Gefter; David S Gierada; Philippe A Grenier; Jonathan Goldin; MeiLan K Han; Nicola A Hanania; Nadia N Hansel; Francine L Jacobson; Hans-Ulrich Kauczor; Vuokko L Kinnula; David A Lipson; David A Lynch; William MacNee; Barry J Make; A James Mamary; Howard Mann; Nathaniel Marchetti; Mario Mascalchi; Geoffrey McLennan; James R Murphy; David Naidich; Hrudaya Nath; John D Newell; Massimo Pistolesi; Elizabeth A Regan; John J Reilly; Robert Sandhaus; Joyce D Schroeder; Frank Sciurba; Saher Shaker; Amir Sharafkhaneh; Edwin K Silverman; Robert M Steiner; Charlton Strange; Nicola Sverzellati; Joseph H Tashjian; Edwin J R van Beek; Lacey Washington; George R Washko; Gloria Westney; Susan A Wood; Prescott G Woodruff
Journal:  COPD       Date:  2012-03-19       Impact factor: 2.409

4.  Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the pittsburgh lung screening study.

Authors:  David O Wilson; Joseph K Leader; Carl R Fuhrman; John J Reilly; Frank C Sciurba; Joel L Weissfeld
Journal:  J Thorac Oncol       Date:  2011-07       Impact factor: 15.609

5.  Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers.

Authors:  Mark P Purdue; Laura Gold; Bengt Järvholm; Michael C R Alavanja; Mary H Ward; Roel Vermeulen
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

6.  Quantitative CT assessment of emphysema and airways in relation to lung cancer risk.

Authors:  David S Gierada; Preethi Guniganti; Blake J Newman; Mark T Dransfield; Paul A Kvale; David A Lynch; Thomas K Pilgram
Journal:  Radiology       Date:  2011-09-07       Impact factor: 11.105

7.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

8.  Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.

Authors:  Juan P de Torres; Gorka Bastarrika; Juan P Wisnivesky; Ana B Alcaide; Arantza Campo; Luis M Seijo; Jesús C Pueyo; Alberto Villanueva; María D Lozano; Usua Montes; Luis Montuenga; Javier J Zulueta
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

9.  Correlation of regional emphysema and lung cancer: a lung tissue research consortium-based study.

Authors:  Laurie A Hohberger; Darrell R Schroeder; Brian J Bartholmai; Ping Yang; Christine H Wendt; Peter B Bitterman; Ola Larsson; Andrew H Limper
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

10.  Chronic obstructive lung diseases and risk of non-small cell lung cancer in women.

Authors:  Ann G Schwartz; Michele L Cote; Angela S Wenzlaff; Alison Van Dyke; Wei Chen; John C Ruckdeschel; Shirish Gadgeel; Ayman O Soubani
Journal:  J Thorac Oncol       Date:  2009-03       Impact factor: 15.609

View more
  16 in total

1.  Post-imaging pulmonary nodule mathematical prediction models: are they clinically relevant?

Authors:  Johanna Uthoff; Nicholas Koehn; Jared Larson; Samantha K N Dilger; Emily Hammond; Ann Schwartz; Brian Mullan; Rolando Sanchez; Richard M Hoffman; Jessica C Sieren
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

2.  COPD-dependent effects of genetic variation in key inflammation pathway genes on lung cancer risk.

Authors:  Donovan Watza; Christine M Lusk; Gregory Dyson; Kristen S Purrington; Angela S Wenzlaff; Christine Neslund-Dudas; Ayman O Soubani; Shirish M Gadgeel; Ann G Schwartz
Journal:  Int J Cancer       Date:  2019-12-12       Impact factor: 7.396

3.  Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer Patients.

Authors:  Christine M Lusk; Donovan Watza; Greg Dyson; Douglas Craig; Valerie Ratliff; Angela S Wenzlaff; Fulvio Lonardo; Aliccia Bollig-Fischer; Gerold Bepler; Kristen Purrington; Shirish Gadgeel; Ann G Schwartz
Journal:  Clin Cancer Res       Date:  2019-04-12       Impact factor: 12.531

4.  Volume doubling time of lung cancer detected in idiopathic interstitial pneumonia: comparison with that in chronic obstructive pulmonary disease.

Authors:  Cherry Kim; Sang Min Lee; Jooae Choe; Eun Jin Chae; Kyung-Hyun Do; Joon Beom Seo
Journal:  Eur Radiol       Date:  2017-10-16       Impact factor: 5.315

5.  Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer.

Authors:  Yanhong Liu; Christine M Lusk; Michael H Cho; Edwin K Silverman; Dandi Qiao; Ruyang Zhang; Michael E Scheurer; Farrah Kheradmand; David A Wheeler; Spiridon Tsavachidis; Georgina Armstrong; Dakai Zhu; Ignacio I Wistuba; Chi-Wan B Chow; Carmen Behrens; Claudio W Pikielny; Christine Neslund-Dudas; Susan M Pinney; Marshall Anderson; Elena Kupert; Joan Bailey-Wilson; Colette Gaba; Diptasri Mandal; Ming You; Mariza de Andrade; Ping Yang; John K Field; Triantafillos Liloglou; Michael Davies; Jolanta Lissowska; Beata Swiatkowska; David Zaridze; Anush Mukeriya; Vladimir Janout; Ivana Holcatova; Dana Mates; Sasa Milosavljevic; Ghislaine Scelo; Paul Brennan; James McKay; Geoffrey Liu; Rayjean J Hung; David C Christiani; Ann G Schwartz; Christopher I Amos; Margaret R Spitz
Journal:  J Thorac Oncol       Date:  2018-07-04       Impact factor: 15.609

6.  Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT.

Authors:  Johanna Uthoff; Matthew J Stephens; John D Newell; Eric A Hoffman; Jared Larson; Nicholas Koehn; Frank A De Stefano; Chrissy M Lusk; Angela S Wenzlaff; Donovan Watza; Christine Neslund-Dudas; Laurie L Carr; David A Lynch; Ann G Schwartz; Jessica C Sieren
Journal:  Med Phys       Date:  2019-06-07       Impact factor: 4.071

7.  Circulating Inflammation Proteins Associated With Lung Cancer in African Americans.

Authors:  Claire L Meaney; Khadijah A Mitchell; Adriana Zingone; Derek Brown; Elise Bowman; Yunkai Yu; Angela S Wenzlaff; Christine Neslund-Dudas; Sharon R Pine; Liang Cao; Ann G Schwartz; Bríd M Ryan
Journal:  J Thorac Oncol       Date:  2019-04-03       Impact factor: 15.609

8.  Computed Tomography Features of Lung Structure Have Utility for Differentiating Malignant and Benign Pulmonary Nodules.

Authors:  Johanna M Uthoff; Sarah L Mott; Jared Larson; Christine M Neslund-Dudas; Ann G Schwartz; Jessica C Sieren
Journal:  Chronic Obstr Pulm Dis       Date:  2022-04-29

9.  Quantitative Imaging Markers of Lung Function in a Smoking Population Distinguish COPD Subgroups with Differential Lung Cancer Risk.

Authors:  Christine M Lusk; Angela S Wenzlaff; Donovan Watza; Jessica C Sieren; Natasha Robinette; Garrett Walworth; Michael Petrich; Christine Neslund-Dudas; Michael J Flynn; Thomas Song; David Spizarny; Michael J Simoff; Ayman O Soubani; Shirish Gadgeel; Ann G Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-14       Impact factor: 4.254

10.  Prognostic modeling of the immune-centric transcriptome reveals interleukin signaling candidates contributing to differential patient outcomes.

Authors:  Donovan Watza; Christine M Lusk; Gregory Dyson; Kristen S Purrington; Kang Chen; Angela S Wenzlaff; Valerie Ratliff; Christine Neslund-Dudas; Gerold Bepler; Ann G Schwartz
Journal:  Carcinogenesis       Date:  2018-12-31       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.